Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Bioequivalence Study to Assess the Systemic Exposure of Fluticasone Propionate and Salmeterol Administered as a Fixed Dose Combination From Different Dry Powder Inhalers in Healthy Subjects

NCT02215122 is registered in ClinicalTrials.gov with Mylan Pharma UK Ltd. as lead sponsor.

NCT NCT02215122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02215122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Bioequivalence Study to Assess the Systemic Exposure of Fluticasone Propionate and Salmeterol Administered as a Fixed Dose Combination From Different Dry Powder Inhalers in Healthy Subjects
Lead sponsor
Mylan Pharma UK Ltd.
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2013
Completion date
November 30, 2013
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, copd